In this study, we first discover some new concept coordinated UD-convex mappings with fuzzy-number values. After that, we look into Hermite-Hadamard type inequalities via fuzzy-number-valued coordinated UD-convex fuzzy-number-valued mapping (coordinated UD-convex FNVM). In the case of coordinated UD-convex FNVM, novel conclusions are derived by making particular decisions in recently proven inequalities. Additionally, it is demonstrated that the recently discovered inequalities are expansions of comparable findings in the literature. It is important to note that the main outcomes are validated by nontrivial examples.

Transportation, environmental conditions, quality of human life within smart cities, and system infrastructure have all needed practical and dependable smart solutions as urbanization has accelerated in recent years. In addition, the emerging Internet of Things (IoT) provides access to a plethora of cutting-edge, all-encompassing apps for smart cities, all of which contribute significantly to lowering energy consumption and other negative environmental impacts. For smart cities to meet the challenge of using less energy, the authors of this research article suggest planning and implementing an integrated power and heat architecture that puts renewable energy infrastructure and energy-storage infrastructure at the top of the list. To address these issues, we describe a smart proposed NEOSRD architecture that uses a distributed smart area domain to optimize renewable demand energy in a smart city across a wide area network. The energy requirements of desalination procedures are negligible when compared to the total local energy consumption and transportation, a feat accomplished by the proposed NEOSRD system. Here, the computational model shows how the established system is a valuable response to our problems and a cost-effective strategy for creating smarter structural elements that cut down on overall smart cities' energy costs.

Schistosomiasis, a crippling ailment that afflicts over 220 million people worldwide. Yet or up till now, there is no vaccine for schistosomiasis, and chemotherapy relies heavily on a single drug, the praziquantel. The present study was undertaken to investigate the therapeutic effect of Monophosphoryl Lipid A (MPLA) as an adjuvant in soluble egg antigen (SEA) vaccinated mice against the deleterious pathological impacts induced in hepatic tissues of mice by Schistosoma mansoni infection. In addition, to study the associated parasitological, immunological and biochemical parameters. Parasitological parameters showed that intraperitoneal injection of MPLA into SEA-vaccinated and S. mansoni-infected mice was effective to a significant degree in reducing the worm and egg burden, granuloma count and diameter as well as the total area of infection in their livers versus SEA-untreated but infected ones. In addition, MPLA showed ameliorative action on the elevated liver oxidative stress marker, including malondialdehyde (MDA) and decrease in the level of the antioxidant enzymes, reduced glutathione (GSH) and catalase (CAT) which may have a role in the liver damage and fibrosis due to S. mansoni infection. In conclusion, treatment with MPLA has multi-functions in attenuating the deleterious impacts of S. mansoni infection in mice livers. Its effects are mediated through a reduction of ova count, worm burden, granuloma diameter and amelioration of antioxidant defense systems, and liver function biomarkers.